Study reveals hidden blood risk in common arthritis drugs
NCT ID NCT07237906
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study examined 122 patients taking TNF-α inhibitors (drugs for rheumatoid arthritis and similar conditions) to find out how often they develop neutropenia—a drop in infection-fighting white blood cells. Researchers looked back at medical records to count cases and see if the condition affected treatment. The goal was to better understand this side effect in real-world patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUTROPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istanbul University - Cerrahpasa (IUC)
Istanbul, 34098, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.